• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) How diet challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-05 (fidaxomicin)]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Overweight and obesity: the efficacy of diets for weight maintenance after weight loss]
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents]
2013     Health Quality Ontario (HQO) Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vandetanib (second assessment) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of occupational therapy for persons with moderate and severe dementia]
2013     Health Quality Ontario (HQO) Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lixisenatide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Agenzia nazionale per i servizi sanitari regionali (Agenas) Selective Internal Radiation Therapy (SIRT) in colorectal liver metastases
2013     Health Quality Ontario (HQO) Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-06 (Abiraterone acetate [New therapeutic indication])]
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in oesophagus cancer]
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: OHTAC recommendation
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colestilan - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis
2013     Basque Office for Health Technology Assessment (OSTEBA) [Evaluating the implementation of diagnostic telemedicine in the field of dermatology]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: OHTAC recommendation
2013     Basque Office for Health Technology Assessment (OSTEBA) [Usefulness of dietary treatments in Lysine metabolic disorders]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sitagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Technology and Policy Unit (HTPU) Level I and level III sleep studies for the diagnosis of sleep disordered breathing (SDB) in adults
2013     Health Quality Ontario (HQO) Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis
2013     Medical Services Advisory Committee (MSAC) Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
2013     Basque Office for Health Technology Assessment (OSTEBA) [Lipid metabolism disorders: review of the indications of fat free dietetic products and nutritional alternatives with regularly consumed foodstuffs]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sitagliptin/Metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: an evidence-based analysis
2013     Basque Office for Health Technology Assessment (OSTEBA) [Economic evaluation of a telemonitoring intervention from primary care in home care patients with cardiac insufficiency and/or chronic bronchial disorders: Cost-effectiveness analysis, TELBIL study]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pertuzumab - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: OHTAC recommendation
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: a health economic literature review
2013     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation and impact of a primary care-based telemonitoring intervention in home care patients with heart failure or chronic lung disease. Randomised controlled trial. The TELBIL study]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vildagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2013     Basque Office for Health Technology Assessment (OSTEBA) [Individualised multidisciplinary care programme in frail patients (PAMI)]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Biologic medications as second-line therapy for rheumatoid arthritis]
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bosutinib - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2013     The Swedish Council on Health Technology Assessment (SBU) [Diagnosis and treatment of ADHD and ASDs (autism spectrum disorders)]
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013     HAYES, Inc. SensiGene fetal RHD genotyping
2013     University of York Inpatient rehabilitation services for the frail elderly
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ocriplasmin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Agency for Healthcare Research and Quality (AHRQ) Pulmonary arterial hypertension: screening, management, and treatment
2013     Health Quality Ontario (HQO) Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013     University of York Evidence briefing on non-pharmacological interventions for dementia in care home settings
2013     Institute for Clinical and Economic Review (ICER) Cardiac nuclear imaging
2013     Basque Office for Health Technology Assessment (OSTEBA) [Alternatives to short stay psychiatric hospitalisation. Intensive ambulatory monitoring programmes]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linaclotide - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Health Quality Ontario (HQO) OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013     University of York Telehealth for patients with long term conditions
2013     Institute for Clinical and Economic Review (ICER) Cervical spinal fusion for degenerative disc disease
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-09 (vandetanib)]
2013     Health Quality Ontario (HQO) OHTAC recommendation: endovascular ablation for varicose veins
2013     NIHR Horizon Scanning Centre (NIHR HSC) The SurroSense Rx™ System for prevention of diabetic foot ulcers
2013     University of York Evidence briefing on urgent care systems
2013     Basque Office for Health Technology Assessment (OSTEBA) [Quality of life of stroke patients and their caregivers. Prognosis and results of rehabilitating treatment]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-10 (pertuzumab)]
2013     Health Quality Ontario (HQO) Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013     NIHR Horizon Scanning Centre (NIHR HSC) ATI™ Neurostimulation System for cluster headache
2013     University of York Consolidating urgent care services
2013     Basque Office for Health Technology Assessment (OSTEBA) [Redesigning maternal education: proposal for a framework to draw up an education programme for health and effective birth preparation focused on the needs of women]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lisdexamfetamine - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous coronary intervention for chronic total occlusion]
2013     Health Quality Ontario (HQO) OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ellex 2RT™ for early age-related macular degeneration
2013     University of York Advance care planning
2013     Basque Office for Health Technology Assessment (OSTEBA) [A study of the use of clinical practice guidelines in specialized care: barriers and facilitators to implementation]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-03 (sitagliptin/metformin)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Implantation of a lumbar artificial endoprosthesis (anuloplasty/anular repair device)]
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) OssDsign™ Cranio PSI for skull repair
2013     University of York Primary care 'in-reach' in hospital settings
2013     Basque Office for Health Technology Assessment (OSTEBA) [Design of an interaction protocol between Primary Care and Hospitals to improve early detection and monitoring of patients with multiple sclerosis]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-16 (vildagliptin)]
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Neurodevelopmental outcome after neonatal hypoglycemia: a multi-center randomized controlled trial comparing intensive treatment versus expectant glucose monitoring in 'high risk' newborns]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Repair of cartilage defects via matrix-associated autologous chondrocyte immigration]
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013     NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013     Medical Services Advisory Committee (MSAC) Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013     Basque Office for Health Technology Assessment (OSTEBA) [Terminal care: systematic review of organisational models in palliative care and survey of health professionals regarding the situation of palliative care in a region of the Basque Country]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A13-17 (vildagliptin/metformin)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)]
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Smart-Glasses depth-based visual aids for the partially sighted
2013     Medical Services Advisory Committee (MSAC) Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013     Basque Office for Health Technology Assessment (OSTEBA) [Results of the perinatal care of very premature children in the health system of the Basque Country]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Endovascular repair of aortic aneurysms]
2013     NIHR Horizon Scanning Centre (NIHR HSC) Full Sense™ device for obesity
2013     Medical Services Advisory Committee (MSAC) Transcatheter closure of patent ductus arteriosus
2013     Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the status, systematic review and validation of a diagnostic algorithm for pulmonary thromboembolism (PTE) in the hospital emergency services of the Basque Health Service]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013     Medical Services Advisory Committee (MSAC) Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
2013     Basque Office for Health Technology Assessment (OSTEBA) [Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]